解码植物干细胞的无限“复刻”：让珍稀药材实现“吨级”生产，技术革命破解千年药源困境｜追寻新质生产力

Core Viewpoint - The article highlights the breakthrough in plant stem cell technology, which allows for the efficient production of rare medicinal plants like ginseng, addressing the scarcity of high-quality traditional Chinese medicine resources [5][6][10]. Group 1: Technology and Innovation - Plant stem cells are crucial for the regeneration of plant organs and the synthesis of secondary metabolites, but their natural occurrence is extremely low [2]. - The technology enables the separation of stem cell lines from rare medicinal plants, such as the century-old wild ginseng, and allows for long-term preservation of genetic resources through low-temperature storage [2][5]. - The induced differentiation of stem cells can produce tons of ginseng adventitious roots in bioreactors, significantly increasing the yield and quality of active ingredients [5][9]. Group 2: Market Impact and Applications - The ginseng adventitious roots produced using this technology have a saponin content of 30,235 mg/kg, which is 14 times that of 15-year-old ginseng, showcasing the technology's potential for high-quality product development [5][9]. - The technology has been successfully applied to other rare medicinal plants, including Taxus chinensis and Tianshan snow lotus, expanding its market potential [6][11]. - The company aims to establish a global "rare plant stem cell bank" to share its resources and innovations with the world [6][14]. Group 3: Industry Standards and Future Prospects - The first technical regulations for ginseng adventitious root tissue culture in China were approved, providing a comprehensive guideline for enterprises and research institutions [13]. - The company has invested 5 billion yuan in a new plant stem cell industrial park, which is expected to become the largest plant stem cell production base globally [11][12]. - The annual output value of the ginseng stem cell series products is projected to exceed 10 billion yuan after full-scale production [12].